Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER climerization inhibitor, in non-small cell lung cancer (NSCLC) patients after prior chemotherapy Meeting Abstract
| Authors: | Herbst, R.; Davies, A.; Johnson, B.; Natale, R.; Dang, T.; Murren, J.; Schiller, J.; Garland, L.; Miller, V.; Mendelson, D.; Melenevsky, Y.; Devries, D.; Van Den Abbeele, A.; Eberhard, D.; Lyons, B.; Lutzker, S. |
| Abstract Title: | Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER climerization inhibitor, in non-small cell lung cancer (NSCLC) patients after prior chemotherapy |
| Meeting Title: | 11th World Conference on Lung Cancer |
| Journal Title: | Lung Cancer |
| Volume: | 49 |
| Issue: | Suppl.2 |
| Meeting Dates: | 2005 Jul 3-6 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0169-5002 |
| Publisher: | Elsevier Ireland Ltd. |
| Date Published: | 2005-07-01 |
| Start Page: | S62 |
| Language: | English |
| DOI: | 10.1016/s0169-5002(05)80321-6 |
| ACCESSION: | WOS:000231307800196 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: O-187 - 11th World Conference on Lung Cancer - JUL 03-06, 2005 - Barcelona, SPAIN - "2" - "Source: Wos" |
